Newbridge Financial Services Group, Inc. Biovie Inc. Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 11, 2024	SELL	$0.4 - $0.56 $1,200 - $1,680	-3,000 Reduced 17.65%	14,000 $5,000
Q1 2024 Apr 24, 2024	BUY	$0.53 - $1.89 $5,830 - $20,790	11,000 Added 183.33%	17,000 $9,000
Q4 2023 Mar 28, 2024	BUY	$1.22 - $5.24 $6,100 - $26,200	5,000 Added 500.0%	6,000 $7,000
Q4 2022 Jan 17, 2023	BUY	$3.86 - $42.0 $3,860 - $42,000	1,000 New	1,000 $0

340K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $64.3M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.